New Food GEA to Develop World's First Pilot Plant for Krill Protein Production

Editor: Ahlam Rais

GEA has been awarded an EPC (engineering, procurement and construction) contract by the biotechnology company Aker BioMarine to establish the world’s first pilot plant for hydrolyzing krill protein. The facility is expected to be operational by 2022.

Related Vendors

With its new pilot plant Aker BioMarine will manufacture INVI, a sustainably sourced krill protein hydrolysate that was recently classified as food safe.
With its new pilot plant Aker BioMarine will manufacture INVI, a sustainably sourced krill protein hydrolysate that was recently classified as food safe.
(Source: Aker BioMarine)

Düsseldorf/Germany – Aker BioMarine is a biotechnology company based in Norway that fishes for Antarctic krill – tiny shrimp-like crustaceans – and uses them to develop ingredients for functional foods, aquaculture and animal feed. Slated to come online in late 2022, the new pilot plant will produce a highly concentrated protein isolate destined for food and beverages. The pilot plant is the next step in commercializing krill human protein powder. It will expand the current small-scale process to a scalable, industrial production level with a capacity of 120 tons per year.

The partners signed the EPC contract, valued in the double-digit million-dollar range, in July 2021.

"Thanks to innovative companies such as Aker BioMarine, the topic of ‘New Food’ is currently developing into an increasingly important future market, which is also of strategic importance for GEA. This is unlocking entirely new sources of human nutrition and health. We are pleased to join Aker BioMarine on their journey into researching and commercializing krill protein - and to do so in a way that is absolutely climate and environmentally friendly," says Ilija Aprcovic, CEO of the Liquid & Powder Technologies Division of GEA Group.

Aker BioMarine intends to decarbonize both its krill fisheries and production.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:47543244)